Periostin (POSTN), found to be upregulated in both breast and prostate cancer stroma, was selected for immunohistochemical validation in a panel of human tumors known to be associated with a prominent stromal reaction (breast, prostate, ovary, colon and lung carcinoma). This evidence concerns the gene POSTN and Familial prostate cancer.